_version_ 1782489821561749504
author Kubuki, Yoko
Shide, Kotaro
Kameda, Takuro
Yamaji, Takumi
Sekine, Masaaki
Kamiunten, Ayako
Akizuki, Keiichi
Shimoda, Haruko
Tahira, Yuki
Nakamura, Kenichi
Abe, Hiroo
Miike, Tadashi
Iwakiri, Hisayoshi
Tahara, Yoshihiro
Sueta, Mitsue
Hashimoto, Kanna
Yamamoto, Shojiro
Hasuike, Satoru
Hidaka, Tomonori
Nagata, Kenji
Kitanaka, Akira
Shimoda, Kazuya
author_facet Kubuki, Yoko
Shide, Kotaro
Kameda, Takuro
Yamaji, Takumi
Sekine, Masaaki
Kamiunten, Ayako
Akizuki, Keiichi
Shimoda, Haruko
Tahira, Yuki
Nakamura, Kenichi
Abe, Hiroo
Miike, Tadashi
Iwakiri, Hisayoshi
Tahara, Yoshihiro
Sueta, Mitsue
Hashimoto, Kanna
Yamamoto, Shojiro
Hasuike, Satoru
Hidaka, Tomonori
Nagata, Kenji
Kitanaka, Akira
Shimoda, Kazuya
author_sort Kubuki, Yoko
collection PubMed
description
format Online
Article
Text
id pubmed-5203995
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Korean Society for Laboratory Medicine
record_format MEDLINE/PubMed
spelling pubmed-52039952017-03-01 Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations Kubuki, Yoko Shide, Kotaro Kameda, Takuro Yamaji, Takumi Sekine, Masaaki Kamiunten, Ayako Akizuki, Keiichi Shimoda, Haruko Tahira, Yuki Nakamura, Kenichi Abe, Hiroo Miike, Tadashi Iwakiri, Hisayoshi Tahara, Yoshihiro Sueta, Mitsue Hashimoto, Kanna Yamamoto, Shojiro Hasuike, Satoru Hidaka, Tomonori Nagata, Kenji Kitanaka, Akira Shimoda, Kazuya Ann Lab Med Letter to the Editor The Korean Society for Laboratory Medicine 2017-03 2016-12-20 /pmc/articles/PMC5203995/ /pubmed/28029004 http://dx.doi.org/10.3343/alm.2017.37.2.159 Text en © The Korean Society for Laboratory Medicine. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Kubuki, Yoko
Shide, Kotaro
Kameda, Takuro
Yamaji, Takumi
Sekine, Masaaki
Kamiunten, Ayako
Akizuki, Keiichi
Shimoda, Haruko
Tahira, Yuki
Nakamura, Kenichi
Abe, Hiroo
Miike, Tadashi
Iwakiri, Hisayoshi
Tahara, Yoshihiro
Sueta, Mitsue
Hashimoto, Kanna
Yamamoto, Shojiro
Hasuike, Satoru
Hidaka, Tomonori
Nagata, Kenji
Kitanaka, Akira
Shimoda, Kazuya
Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations
title Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations
title_full Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations
title_fullStr Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations
title_full_unstemmed Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations
title_short Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations
title_sort differences in hematological and clinical features between essential thrombocythemia cases with jak2- or calr-mutations
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203995/
https://www.ncbi.nlm.nih.gov/pubmed/28029004
http://dx.doi.org/10.3343/alm.2017.37.2.159
work_keys_str_mv AT kubukiyoko differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT shidekotaro differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT kamedatakuro differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT yamajitakumi differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT sekinemasaaki differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT kamiuntenayako differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT akizukikeiichi differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT shimodaharuko differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT tahirayuki differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT nakamurakenichi differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT abehiroo differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT miiketadashi differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT iwakirihisayoshi differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT taharayoshihiro differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT suetamitsue differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT hashimotokanna differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT yamamotoshojiro differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT hasuikesatoru differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT hidakatomonori differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT nagatakenji differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT kitanakaakira differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations
AT shimodakazuya differencesinhematologicalandclinicalfeaturesbetweenessentialthrombocythemiacaseswithjak2orcalrmutations